126 related articles for article (PubMed ID: 31599127)
1. Polymorphisms of CHRNA3 and CHRNA5: Head and neck cancer and cigarette consumption intensity in a Brazilian population.
Silva MR; Gattás GJF; De Antonio J; Firigato I; Curioni OA; Gonçalves FT
Mol Genet Genomic Med; 2019 Dec; 7(12):e998. PubMed ID: 31599127
[TBL] [Abstract][Full Text] [Related]
2. CHRNA3 rs1051730 and CHRNA5 rs16969968 polymorphisms are associated with heavy smoking, lung cancer, and chronic obstructive pulmonary disease in a mexican population.
Pérez-Morales R; González-Zamora A; González-Delgado MF; Calleros Rincón EY; Olivas Calderón EH; Martínez-Ramírez OC; Rubio J
Ann Hum Genet; 2018 Nov; 82(6):415-424. PubMed ID: 29993116
[TBL] [Abstract][Full Text] [Related]
3. Nicotinic acetylcholine gene cluster CHRNA5-A3-B4 variants influence smoking status in a Bangladeshi population.
Chaity NI; Sultana TN; Hasan MM; Shrabonee II; Nahid NA; Islam MS; Apu MNH
Pharmacol Rep; 2021 Apr; 73(2):574-582. PubMed ID: 33675519
[TBL] [Abstract][Full Text] [Related]
4. Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism.
Wen L; Jiang K; Yuan W; Cui W; Li MD
Mol Neurobiol; 2016 Jan; 53(1):472-484. PubMed ID: 25471942
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.
Tomaz PRX; Santos JR; Scholz J; Abe TO; Gaya PV; Negrão AB; Krieger JE; Pereira AC; Santos PCJL
BMC Med Genet; 2018 Apr; 19(1):55. PubMed ID: 29621993
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms in CHRNA5 rs16969968, CHRNA3 rs578776, and LOC123688 rs8034191 are associated with heaviness of smoking in women in Northeastern Ontario, Canada.
Conlon MS; Bewick MA
Nicotine Tob Res; 2011 Nov; 13(11):1076-83. PubMed ID: 21810735
[TBL] [Abstract][Full Text] [Related]
7. Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance.
Winterer G; Mittelstrass K; Giegling I; Lamina C; Fehr C; Brenner H; Breitling LP; Nitz B; Raum E; Müller H; Gallinat J; Gal A; Heim K; Prokisch H; Meitinger T; Hartmann AM; Möller HJ; Gieger C; Wichmann HE; Illig T; Dahmen N; Rujescu D
Am J Med Genet B Neuropsychiatr Genet; 2010 Dec; 153B(8):1448-58. PubMed ID: 20886544
[TBL] [Abstract][Full Text] [Related]
8. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.
Wassenaar CA; Dong Q; Wei Q; Amos CI; Spitz MR; Tyndale RF
J Natl Cancer Inst; 2011 Sep; 103(17):1342-6. PubMed ID: 21747048
[TBL] [Abstract][Full Text] [Related]
9.
Chaity NI; Apu MNH
Heliyon; 2022 Jul; 8(7):e09947. PubMed ID: 35865987
[TBL] [Abstract][Full Text] [Related]
10. Combined genetic influence of the nicotinic receptor gene cluster CHRNA5/A3/B4 on nicotine dependence.
Lee SH; Ahn WY; Seweryn M; Sadee W
BMC Genomics; 2018 Nov; 19(1):826. PubMed ID: 30453884
[TBL] [Abstract][Full Text] [Related]
11. Combined analysis of CHRNA5, CHRNA3 and CYP2A6 in relation to adolescent smoking behaviour.
Rodriguez S; Cook DG; Gaunt TR; Nightingale CM; Whincup PH; Day IN
J Psychopharmacol; 2011 Jul; 25(7):915-23. PubMed ID: 21765098
[TBL] [Abstract][Full Text] [Related]
12. Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine.
Le Marchand L; Derby KS; Murphy SE; Hecht SS; Hatsukami D; Carmella SG; Tiirikainen M; Wang H
Cancer Res; 2008 Nov; 68(22):9137-40. PubMed ID: 19010884
[TBL] [Abstract][Full Text] [Related]
13. Single-nucleotide polymorphisms in nucleotide excision repair genes, cigarette smoking, and the risk of head and neck cancer.
Wyss AB; Herring AH; Avery CL; Weissler MC; Bensen JT; Barnholtz-Sloan JS; Funkhouser WK; Olshan AF
Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1428-45. PubMed ID: 23720401
[TBL] [Abstract][Full Text] [Related]
14. Peer smoking and the nicotinic receptor genes: an examination of genetic and environmental risks for nicotine dependence.
Johnson EO; Chen LS; Breslau N; Hatsukami D; Robbins T; Saccone NL; Grucza RA; Bierut LJ
Addiction; 2010 Nov; 105(11):2014-22. PubMed ID: 20840187
[TBL] [Abstract][Full Text] [Related]
15. CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in Alaska Native tobacco users.
Zhu AZ; Renner CC; Hatsukami DK; Benowitz NL; Tyndale RF
Addiction; 2013 Oct; 108(10):1818-28. PubMed ID: 23692359
[TBL] [Abstract][Full Text] [Related]
16. Association of Polymorphism
Chmielowiec K; Chmielowiec J; Strońska-Pluta A; Trybek G; Śmiarowska M; Suchanecka A; Woźniak G; Jaroń A; Grzywacz A
Int J Environ Res Public Health; 2022 Aug; 19(17):. PubMed ID: 36078193
[TBL] [Abstract][Full Text] [Related]
17. The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.
Barrie ES; Hartmann K; Lee SH; Frater JT; Seweryn M; Wang D; Sadee W
Hum Mutat; 2017 Jan; 38(1):112-119. PubMed ID: 27758088
[TBL] [Abstract][Full Text] [Related]
18. CHRNA5/CHRNA3 gene cluster is a risk factor for lumbar disc herniation: a case-control study.
Yang X; Guo X; Huang Z; Da Y; Xing W; Li F; Li M; Sun K; Jia H; Zhu Y
J Orthop Surg Res; 2019 Jul; 14(1):243. PubMed ID: 31362771
[TBL] [Abstract][Full Text] [Related]
19. Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers.
Falcone M; Jepson C; Benowitz N; Bergen AW; Pinto A; Wileyto EP; Baldwin D; Tyndale RF; Lerman C; Ray R
Nicotine Tob Res; 2011 Jun; 13(6):498-503. PubMed ID: 21385908
[TBL] [Abstract][Full Text] [Related]
20. In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression.
Doyle GA; Wang MJ; Chou AD; Oleynick JU; Arnold SE; Buono RJ; Ferraro TN; Berrettini WH
PLoS One; 2011; 6(8):e23373. PubMed ID: 21858091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
